| Source | Human 293 Cells |
M.W. | 45kDa |
CAS No. | |
| Structural Info |
|
| Formulation | Lyophilized in sterile filtered solution of PBS. |
| Reconstitution | Before reconstitution, a brief spin is recommend to drive down any material dislodged from the bottom of the tube. The lyophilized protein should be reconstituted in sterile H2O to a desired concentration.
|
| Stability | The lyophilized protein is stable for at least one year if stored at -80 °C. Reconstituted protein is stable for at least four weeks at 4 °C, but should be stored in aliquots at -80 °C for longer term. Avoid repeated freeze and thaw. |
| Purity | Greater than 95% as determined by SDS-PAGE analysis and visualized by silver staining. |
| Biological Activity | The activity was determined by using a HUVEC cells. The ED 50 ranges from 2- 10 ng/ml. Activity in other assays should be determined by each individual setting. |
| Country of Origin | USA |
VEGF is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, it plays a prominent role in normal and pathological angiogenesis. StemRD’s VEGF-165 is made in human 293 cells as a 45kDa glycoprotein consisting of two 165 amino acid polypeptide chains. It is purified by aseries of chromatography.
|
Catalog No.
|
Size
|
|
VEGF-010
|
10 µg
|
|
VEGF-050
|
50 µg
|
|
VEGF-250
|
250 µg
|
|
VEGF-1000
|
1000 µg
|
